Evoxac and Faslodex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Evoxac (cevimeline hydrochloride) and Faslodex (fulvestrant). Common drug interactions include pain among females and scar among males.

The phase IV clinical study analyzes what interactions people have when they take Evoxac and Faslodex. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Evoxac?

Evoxac has active ingredients of cevimeline hydrochloride. It is often used in sjogren syndrome. eHealthMe is studying from 2,028 Evoxac users. Check the latest studies of Evoxac.

What is Faslodex?

Faslodex has active ingredients of fulvestrant. It is often used in breast cancer metastatic. eHealthMe is studying from 19,255 Faslodex users. Check the latest studies of Faslodex.



On Jul, 16, 2026

49 people who take Evoxac and Faslodex together, and have interactions are studied.

Evoxac and Faslodex drug interactions.

What are the common drug interactions of Evoxac and Faslodex, by gender? *:

female:

  1. Pain
  2. Pain in jaw
  3. Bone disorder
  4. Injury
  5. Palpitations (feelings or sensations that your heart is pounding or racing)
  6. Dizziness
  7. Neck pain
  8. Hypertonic bladder (bladder-storage function that causes a sudden urge to urinate)
  9. Diarrhoea
  10. Dyspnoea (difficult or laboured respiration)

male:

  1. Scar
  2. Acute sinusitis
  3. Bone loss
  4. Candidiasis (candidiasis or thrush is a fungal infection)
  5. Cellulitis (infection under the skin)
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  8. Constipation
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Decreased appetite

What are the common drug interactions of Evoxac and Faslodex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Scar
  2. Acute sinusitis
  3. Anaemia (lack of blood)
  4. Angiopathy (generic term for a disease of the blood vessels)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Aortic arteriosclerosis (hardening of the aortic arteries)
  8. Arthropathy
  9. Back pain
  10. Bone disorder

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Dizziness
  2. Emotional distress
  3. Epistaxis (bleed from the nose)
  4. Eye infection
  5. Eye pain
  6. Facial bones fracture (bone fracture of face)
  7. Fall
  8. Femur fracture
  9. Glossitis (infection of tongue with soreness)
  10. Groin pain

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Anxiety
  3. Pain in jaw
  4. Palpitations (feelings or sensations that your heart is pounding or racing)
  5. Spinal osteoarthritis (joint cartilage loss in spine)
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Aortic arteriosclerosis (hardening of the aortic arteries)
  8. Back pain
  9. Bone disorder
  10. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 21 people, 42.86%
  2. Breast Cancer: 8 people, 16.33%
  3. Metastases To Bone (cancer spreads to bone): 6 people, 12.24%
  4. Multiple Myeloma (cancer of the plasma cells): 4 people, 8.16%
  5. High Blood Pressure: 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Evoxac and Faslodex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Evoxac and Faslodex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Evoxac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Faslodex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Evoxac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Faslodex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cevimeline hydrochloride and fulvestrant (the active ingredients of Evoxac and Faslodex, respectively), and Evoxac and Faslodex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: